Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Comment by Bellseyon Nov 17, 2017 12:12pm
122 Views
Post# 26984633

RE:Hang in there!

RE:Hang in there!Selling would be stupid and dangerous right now imo. This isn't a hype stock for retailers like some of the other pennies. LIB plan may not look 'sexy' (i.e. no plans to build huge greenhouses), but through the distribution channel will likely make a killing. I don't think the sales license is fully built into the SP yet either. Look back at some of the napkin math that was done in this forum months ago. A lot of us predicted we would see high 20's before the license news was even made. 

My favourite part about this company is the risk/reward level. There is really no need to go deep in debt with a facility like North Roads. My understanding is that there is even more room for the vault to be increased. I had some trouble at first understanding or even predicting the revenue that could be generated with NR. After talks with some of the members here, and a phone call to the company, I'm under the impression that there is tons of growth potential in the estimates provided in the Financial Post article. 

What will part two of the FP article talk about? Thinking the scientific trials with ESEV.
Anyways, when I first bought into LIB I thought let's hope for a buyout by one of the big guys, and get a quick 100% return. Would be terrible now. These guys are taking the right steps. Not afraid to cut their losses (California endeavours), and doubling down in where the easy profits will be (increasing vault at NR).  

Just some 2 cents from me. As always, call the company if you have questions. I'm just a retail guy with high hopes. 
<< Previous
Bullboard Posts
Next >>